Cargando…

Involved-field radiation therapy for selected cases of recurrent ovarian cancer

OBJECTIVES: In our institutional experience, involved-field radiation therapy (IFRT) yields favorable outcomes in patients with recurrent epithelial ovarian cancer (EOC). This retrospective study aimed to investigate the clinical benefits of IFRT in this patient population. METHODS: Among patients t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Nalee, Chang, Jee Suk, Kim, Sang Wun, Kim, Gun Min, Lee, Jung-Yun, Kim, Yong Bae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658600/ https://www.ncbi.nlm.nih.gov/pubmed/31328453 http://dx.doi.org/10.3802/jgo.2019.30.e67

Ejemplares similares

Atlas-based auto-segmentation for postoperative radiotherapy planning in endometrial and cervical cancers
por: Kim, Nalee, et al.
Publicado: (2020)

Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapy
por: Chang, Jee Suk, et al.
Publicado: (2013)

Feasibility of Continual Deep Learning-Based Segmentation for Personalized Adaptive Radiation Therapy in Head and Neck Area
por: Kim, Nalee, et al.
Publicado: (2021)

Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy in the Treatment of Breast Cancer: An Updated Review
por: Chang, Jee Suk, et al.
Publicado: (2022)

Impact of Oncotype DX Recurrence Score on the Patterns of Locoregional Recurrence in Breast Cancer (Korean Radiation Oncology Group 19-06)
por: Kim, Kyubo, et al.
Publicado: (2020)

Simple calculation using anatomical features on pre-treatment verification CT for bladder volume estimation during radiation therapy for rectal cancer
por: Kim, Nalee, et al.
Publicado: (2020)

Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue
por: Nam, Eun Ji, et al.
Publicado: (2016)

Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer
por: Chang, Jee Suk, et al.
Publicado: (2020)

Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates
por: Kim, Nalee, et al.
Publicado: (2022)

Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC)
por: Kim, Yong Bae, et al.
Publicado: (2023)

Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid–upper rectal cancer
por: Choi, Seo Hee, et al.
Publicado: (2017)

Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers
por: Jeon, Seob, et al.
Publicado: (2017)

High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer
por: Bae, Sun Hyun, et al.
Publicado: (2012)

Robotic Surgery in Gynecologic Field
por: Kim, Young Tae, et al.
Publicado: (2008)

Recent Updates on Radiation Therapy for Pediatric Optic Pathway Glioma
por: Kim, Nalee, et al.
Publicado: (2022)

External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence
por: Lee, Byung Min, et al.
Publicado: (2018)

Radiation for persistent or recurrent epithelial ovarian cancer: a need for reassessment
por: Choi, Noorie, et al.
Publicado: (2017)

Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis
por: Yoon, Hong In, et al.
Publicado: (2015)

Predictive value of interim (18)F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy
por: Kim, Nalee, et al.
Publicado: (2020)

Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy
por: Cho, Won Kyung, et al.
Publicado: (2021)

Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure
por: Kim, Nalee, et al.
Publicado: (2022)

ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer
por: Lee, Maria, et al.
Publicado: (2014)

Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06)
por: Kim, Nalee, et al.
Publicado: (2021)

A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution
por: Nam, Seon Mi, et al.
Publicado: (2017)

Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer
por: Son, Joo-Hyuk, et al.
Publicado: (2022)

Hypofractionated Radiotherapy Dose Scheme and Application of New Techniques Are Associated to a Lower Incidence of Radiation Pneumonitis in Breast Cancer Patients
por: Lee, Byung Min, et al.
Publicado: (2020)

Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
por: Lee, Yong Jae, et al.
Publicado: (2022)

Patterns and Longitudinal Changes in the Practice of Breast Cancer Radiotherapy in Korea: Korean Radiation Oncology Group 22-01
por: Park, Hae Jin, et al.
Publicado: (2023)

(18)F-FDG/PET May Help to Identify a Subgroup of Patients with T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes Who Are at a High Risk of Recurrence after Mastectomy
por: Chang, Jee Suk, et al.
Publicado: (2016)

Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Lee, Yong Jae, et al.
Publicado: (2020)

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2019)

Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection
por: Chung, Seung Yeun, et al.
Publicado: (2019)

Oocyte maturity in repeated ovarian stimulation
por: Lee, Jae Eun, et al.
Publicado: (2011)

Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2022)

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
por: Eoh, Kyung Jin, et al.
Publicado: (2020)

Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
por: Kim, Yoo-Na, et al.
Publicado: (2019)

Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer
por: Lee, Yong Jae, et al.
Publicado: (2019)

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2020)

Genetic analysis of ovarian microcystic stromal tumor
por: Lee, Jae Hoon, et al.
Publicado: (2016)

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
por: Lee, Yong Jae, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jik4v50f002ppdj6a269u42c9a